Comparing Guided Therapeutics (OTCMKTS:GTHP) & Modular Medical (NASDAQ:MODD)

Guided Therapeutics (OTCMKTS:GTHP) and Modular Medical (NASDAQ:MODD) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, institutional ownership, dividends, risk, earnings, analyst recommendations and profitability.

Insider and Institutional Ownership

9.7% of Guided Therapeutics shares are held by institutional investors. Comparatively, 27.5% of Modular Medical shares are held by institutional investors. 66.8% of Guided Therapeutics shares are held by company insiders. Comparatively, 7.1% of Modular Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Risk and Volatility

Guided Therapeutics has a beta of 0.79, meaning that its stock price is 21% less volatile than the S&P 500. Comparatively, Modular Medical has a beta of 0.24, meaning that its stock price is 76% less volatile than the S&P 500.

Profitability

This table compares Guided Therapeutics and Modular Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Guided Therapeutics	N/A	N/A	-304.40%
Modular Medical	N/A	-245.85%	-190.80%

Analyst Ratings

This is a summary of recent ratings for Guided Therapeutics and Modular Medical, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guided Therapeutics	0	0	0	0	0.00
Modular Medical	1	0	0	0	1.00

Earnings & Valuation

This table compares Guided Therapeutics and Modular Medical”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guided Therapeutics	$770,000.00	25.08	-$3.20 million	($0.04)	-5.00
Modular Medical	N/A	N/A	-$18.82 million	($14.71)	-0.26

Guided Therapeutics has higher revenue and earnings than Modular Medical. Guided Therapeutics is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks.

Summary

Guided Therapeutics beats Modular Medical on 6 of the 10 factors compared between the two stocks.

About Guided Therapeutics

Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.

About Modular Medical

Modular Medical, Inc. operates as a medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. The company is headquartered in San Diego, California.